文献速递眼底病与葡萄膜炎

新生血管性年龄相关性黄斑变性患者接受布西珠单抗治疗后发生眼内炎症的相关因素

Factors Associated With Intraocular Inflammation in Neovascular Age-Related Macular Degeneration Patients Treated With Brolucizumab.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2024-01-01

这项前瞻性观察研究收集了96例接受布西珠单抗治疗的新生血管性年龄相关性黄斑变性患者的房水样本,其中19例随后发生眼内炎症。研究发现,眼内炎症组房水中P-选择素、TNF-α和IL-1α水平升高,血清MMP-9浓度升高,血浆Th2细胞比例降低,多指标联合模型评估眼内炎症发生可能性的曲线下面积为0.71至0.89。

要点

  • 眼内炎症组房水P-选择素为584 pg/mL,非眼内炎症组为324 pg/mL(P=0.013)。
  • 眼内炎症组血清MMP-9为18,310 pg/mL,非眼内炎症组为13,450 pg/mL(P=0.029)。
  • 眼内炎症组血浆Th2细胞比例为3.1%,非眼内炎症组为4.2%(P=0.013)。

核心结论

  • 多种房水细胞因子浓度升高、血清MMP-9浓度升高及血浆Th2细胞数量降低的组合与新生血管性年龄相关性黄斑变性患者布西珠单抗相关眼内炎症有关。

研究设计与样本

  • 前瞻性观察研究,收集96例(96只眼)接受布西珠单抗治疗的新生血管性年龄相关性黄斑变性患者的房水样本,其中19例(19只眼)随后发生眼内炎症。
  • 另收集20例发生眼内炎症的患者及20例年龄和性别匹配的对照者的血浆,以识别血浆生物标志物及CD4+细胞亚群的差异。
  • 采用逐步变量选择和多变量二元回归分析开发评估眼内炎症发生可能性的算法。

主要发现

  • 眼内炎症组房水P-选择素为584 pg/mL,非眼内炎症组为324 pg/mL(P=0.013)。
  • 眼内炎症组房水TNF-α为0.89 pg/mL,非眼内炎症组为0.60 pg/mL(P=0.018)。
  • 眼内炎症组房水IL-1α为2.0 pg/mL,非眼内炎症组为1.4 pg/mL(P=0.035)。
  • 眼内炎症组血清MMP-9浓度为18,310 pg/mL,非眼内炎症组为13,450 pg/mL(P=0.029)。
  • 眼内炎症组血浆Th2细胞百分比为3.1%,非眼内炎症组为4.2%,眼内炎症组显著降低(P=0.013)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To identify factors associated with intraocular inflammation (IOI) in patients with neovascular age-related macular degeneration (nAMD) treated with brolucizumab. METHODS: In this prospective observational study, we collected aqueous humor samples from 96 eyes of 96 patients receiving treatment with brolucizumab; IOI subsequently developed in 19 eyes of 19 patients. To identify cytokines upregulated in eyes with subsequent development of IOI, we compared the aqueous humor cytokine levels between the IOI and non-IOI groups. We also collected plasma from 20 patients who developed IOI and 20 age- and sex-matched controls to identify differences in plasma biomarkers and the subfraction of CD4+ cells. Using stepwise variable selection and multivariate binary regression analysis, we developed an algorithm that accurately assessed the likelihood of IOI occurrence. RESULTS: The IOI group showed elevated aqueous humor levels of P-selectin (584 vs. 324 pg/mL, P = 0.013), TNF-α (0.89 vs. 0.60 pg/mL, P = 0.018), and IL-1α (2.0 vs. 1.4 pg/mL, P = 0.035) compared with the non-IOI group. Serum MMP-9 concentrations were higher in the IOI group than the non-IOI group (18,310 vs. 13,450 pg/mL, P = 0.029). Furthermore, the percentage of Th2 cells was significantly decreased in the IOI compared with the non-IOI group (3.1% vs. 4.2%, P = 0.013). The receiver operating characteristic curves for the optimal models showed an area under the curve ranging from 0.71 to 0.89, indicating good performance. CONCLUSIONS: The combination of elevated concentrations of multiple aqueous humor cytokines and of serum MMP-9 and a lower number of plasma Th2 cells is associated with brolucizumab-related IOI in patients with nAMD.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Hashimoto Y, Inoda S, Takahashi H, et al. Factors Associated With Intraocular Inflammation in Neovascular Age-Related Macular Degeneration Patients Treated With Brolucizumab. Invest Ophthalmol Vis Sci. 2024. PMID: 38170536. doi:10.1167/iovs.65.1.8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。